Albany, NY (PRWEB) April 04, 2013
Growth in the market for non-public hospitals in the Central European countries of Bulgaria, the Czech Republic, Hungary, Poland, Romania and Slovakia has been curtailed, to a degree, by lack of ability to spend large amounts on private healthcare in these six countries. Populations more commonly use public healthcare systems, but the affluent are increasingly turning to private hospitals in order to take advantage of faster service and higher quality care.
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis/165063
Changes in the field of healthcare, combined with advancing economies, have prepared the private sector for potential growth that was unexpected until recently. Non-public hospitals market in Central Europe 2013, Comparative analysis and development prospects is an insightful document from PMR that analyses the central market issues and predicts opportunities created by developments over the next few years.
This report, prepared by experienced analysts monitoring the market, presents detailed analyses of the conditions and expectations for non-public hospitals in Bulgaria, the Czech Republic, Hungary, Poland, Romania and Slovakia. It covers major hospital transformations from public to private ownership, examines obstacles and prospects, and describes in detail the consequences of upcoming legislative changes on market growth and expansion.
Latest Report: Construction sector in Bulgaria 2013
The publication delivers concrete statistics that describe the market and its scope, including: total bed numbers for the region’s largest private hospitals, number of transformations, newly-built non-public hospitals, funding and investment sources for non-public hospitals, details of contracts between third-party payers and private hospitals and corporate profiles of the most well-known non-public hospitals that explore operational and revenue strategies. All of this information is provided as it applies to each of the six countries covered by the report.
Readers will benefit from guidance in areas such as: the best locations for new non-public hospitals in CE, insight on the financial structures of large and successful hospitals, CE countries where privatisation is a more lengthy process, legislation and its specific impacts on the market, upcoming openings of new facilities and financial status of the current markets in each country. This one-of-a-kind publication combines market analysis, data and expert forecasts to create an indispensible business tool for use by professionals engaged in monitoring or actively participating in the non-public hospital sector in Central Europe.
Technology Report: Telecommunications Equipment Markets in China
The information contained in Non-public hospitals market in Central Europe 2013, Comparative analysis and development prospects is particularly useful for companies involved in the establishment or transformation of new private medical facilities, or expanding on an existing framework of hospitals in order to accommodate more patients and/or additional services. It can help financial and investment firms to evaluate and plan transactions, and aid governmental and research institutions in achieving a clear understanding of this unique market and its potential for growth in the coming years.
X-ray Systems Market to 2019 – Enhanced Imaging Capability, Better Procedural Efficiency and Portability to Drive Future Growth of Digital X-ray Systems looks at the market, competitive landscape, and trends for the three X-ray systems market segments: digital X-ray systems, analog X-ray systems and retrofit X-ray systems. The report provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape and gives a detailed analysis of each segment’s pipeline products, as well as details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
Adult and Adolescent Vaccines Market to 2018. The report provides insights into the vaccines in the adult and adolescent vaccines market, including market forecasts up to 2018. It provides an in-depth analysis of the vaccines for the adult and adolescent market, as well as insights into the adult and adolescent vaccines market’s Research and Development (R&D) pipeline. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global adult and adolescent vaccines market. The report analyzes the market for adult and adolescent vaccines in the US, and the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. The report discusses the global pipeline for adult and adolescent vaccines across various stages of development. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. GBI Research found that the adult and adolescent vaccines market in the top seven markets was valued at $7.2 billion in 2011, increasing at a Compound Annual Growth Rate (CAGR) of 6.9% during the 2007–2011 historic period. The market is projected to witness a growth of 5.6% during the 2011–2018 forecast period to reach $10.5 billion.
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants which essentially provides insights into the seasonal influenza vaccine sales forecasts for the Asia-Pacific Region until 2018. The report also delves deep into vaccination patterns for seasonal influenza in the Asia-Pacific Region. Further, the geographical distribution of seasonal influenza vaccines across Japan, Australia, New Zealand, China, Taiwan, Philippines, Hong Kong, Malaysia, India and Singapore are also provided in the report.
For All Market Research Reports visit: http://www.marketresearchreports.biz/